MIKEL
TAINTA CUEZVA
VU University Amsterdam
Ámsterdam, HolandaVU University Amsterdam-ko ikertzaileekin lankidetzan egindako argitalpenak (10)
2024
-
Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD study
Alzheimer's and Dementia
-
Blood-based multivariate methylation risk score for cognitive impairment and dementia
Alzheimer's and Dementia
-
CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
Alzheimer's and Dementia
-
Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies
Fluids and Barriers of the CNS, Vol. 21, Núm. 1
2023
-
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia
Human Brain Mapping, Vol. 44, Núm. 7, pp. 2684-2700
-
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology
Alzheimer's and Dementia, Vol. 19, Núm. 3, pp. 807-820
-
Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
Genome Medicine, Vol. 15, Núm. 1
2021
-
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels
Alzheimer's and Dementia, Vol. 17, Núm. 10, pp. 1628-1640
2020
-
Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset
Translational Psychiatry, Vol. 10, Núm. 1
2019
-
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort
Alzheimer's and Dementia: Translational Research and Clinical Interventions, Vol. 5, pp. 933-938